Sofia, Bulgaria, May 5, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for April 2022 the Company recorded an increase in sales of 44% compared to the same month of the previous year, incl. 60% increase in domestic sales and 38% increase in export sales as a result of erratic recovery of activity in major foreign markets.